Apyx Medical (APYX) Assets (2010 - 2026)

Apyx Medical (APYX) has 17 years of Assets data on file, last reported at $63.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 4.76% year-over-year to $63.0 million; the trailing twelve-month figure through Mar 2026 stood at $63.0 million (up 4.76% YoY), and the FY2025 full-year result was $66.8 million, up 3.08% from the prior year.
• Assets for Q1 2026 stood at $63.0 million, down from $66.8 million in the prior quarter.
• Across five years, Assets topped out at $79.2 million in Q4 2023 and bottomed at $51.8 million in Q4 2022.
• The 5-year median for Assets is $60.7 million (2024), against an average of $62.0 million.
• The widest annual swing landed in 2022, when Assets retreated 24.66%; it then soared 53.05% in 2023.
• A 5-year view of Assets shows it stood at $51.8 million in 2022, then jumped by 53.05% to $79.2 million in 2023, then dropped by 18.17% to $64.8 million in 2024, then rose by 3.08% to $66.8 million in 2025, then dropped by 5.71% to $63.0 million in 2026.
• The last three Assets figures came in at $63.0 million (Q1 2026), $66.8 million (Q4 2025), and $57.4 million (Q3 2025), per Business Quant data.

Peer Comparison